Clinical trial
Randomized Ablation-based Atrial Fibrillation Rhythm-control Versus Rate-control Trial in Patients With Heart Failure and High-burden Atrial Fibrillation Extend
NCT05118893 is registered in ClinicalTrials.gov with Anthony Tang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Ablation-based Atrial Fibrillation Rhythm-control Versus Rate-control Trial in Patients With Heart Failure and High-burden Atrial Fibrillation Extend
- Lead sponsor
- Anthony Tang
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 8, 2023
- Completion date
- August 30, 2024
- Enrollment
- 324 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.